Suppr超能文献

肾癌(RCC)患者延迟手术干预后的生长模式。

Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention.

机构信息

Department of Urology, First Hospital of Peking University, Institute of Urology, Peking University, National Urological Cancer Center, No. 8 Xishiku St, Xicheng District, Beijing, 100034, China.

出版信息

J Cancer Res Clin Oncol. 2012 Feb;138(2):269-74. doi: 10.1007/s00432-011-1083-0. Epub 2011 Nov 22.

Abstract

PURPOSE

Few studies have evaluated the growth pattern of renal cell carcinoma (RCC) in patients with delayed treatment. This report investigated the growth rate and stage progression of incidentally discovered RCC following a long period of active surveillance.

METHODS

Thirty-two patients who did not receive immediate surgical treatment for renal solid masses that later proved to be RCC were reviewed retrospectively. Annual tumor growth rates were calculated according to changes in the maximal diameter on CT or MRI. Clinical and pathological characteristics associated with tumor growth rate and stage progression were analyzed.

RESULTS

The median tumor size grow from 2.14 (range, 0.30-6.70) cm to 4.33 (range, 1.40-8.80) cm after a median 46.0 months observation period. The average tumor growth rate was 0.80 (range, 0.16-3.80) cm/year. Clear cell carcinoma (0.86 cm/year) tended to grow faster than papillary cell carcinoma (0.28 cm/year) (P = 0.066). The mean growth rate of grade 2 tumors (0.88 cm/year) was faster than that of grade 1 tumors (0.36 cm/year) (P = 0.041). Thirteen tumors (40.6%) were upstaged at a median 48 months after initial presentation. Cox regression analysis revealed initial tumor size as the only risk factor for upstaging (P = 0.018). No local and systemic recurrences were noted in our cohort after the intervention at a median of 47 (range, 6-248) months of follow-up.

CONCLUSIONS

RCCs were found to be slow growing in a group of untreated renal cell carcinoma patients. However, some tumors progressed in stage under observation. The growth rate of RCC tended to correlate with histologic grade and histologic subtype.

摘要

目的

很少有研究评估延迟治疗后肾细胞癌 (RCC) 的生长模式。本报告调查了经过长时间积极监测后偶然发现的 RCC 的生长速度和分期进展。

方法

回顾性分析 32 例未接受立即手术治疗的肾实性肿块患者的资料,这些肿块后来证实为 RCC。根据 CT 或 MRI 上最大直径的变化计算年度肿瘤生长率。分析与肿瘤生长率和分期进展相关的临床和病理特征。

结果

中位肿瘤大小从 2.14cm(范围,0.30-6.70cm)增长至 4.33cm(范围,1.40-8.80cm),中位观察时间为 46.0 个月。平均肿瘤生长率为 0.80cm/年(范围,0.16-3.80cm/年)。透明细胞癌(0.86cm/年)的生长速度快于乳头状细胞癌(0.28cm/年)(P=0.066)。2 级肿瘤的平均生长率(0.88cm/年)快于 1 级肿瘤(0.36cm/年)(P=0.041)。13 例肿瘤(40.6%)在初始表现后中位 48 个月时分期升级。Cox 回归分析显示,初始肿瘤大小是分期升级的唯一危险因素(P=0.018)。在中位随访 47 个月(范围,6-248 个月)后,我们的队列中未发现局部和全身复发。

结论

在一组未经治疗的 RCC 患者中,RCC 被发现生长缓慢。然而,一些肿瘤在观察过程中进展为晚期。RCC 的生长速度似乎与组织学分级和组织学亚型相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验